QuantaMatrix (A317690) Stock Overview
Operates as an in-vitro diagnostics company in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A317690 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
QuantaMatrix Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,770.00 |
| 52 Week High | ₩6,550.00 |
| 52 Week Low | ₩2,920.00 |
| Beta | 0.14 |
| 1 Month Change | 0.67% |
| 3 Month Change | -11.71% |
| 1 Year Change | 5.16% |
| 3 Year Change | -22.03% |
| 5 Year Change | -73.73% |
| Change since IPO | -84.36% |
Recent News & Updates
Does QuantaMatrix (KOSDAQ:317690) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...QuantaMatrix (KOSDAQ:317690) Has Debt But No Earnings; Should You Worry?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Recent updates
Shareholder Returns
| A317690 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -10.6% | -3.1% | 11.7% |
| 1Y | 5.2% | 40.0% | 184.4% |
Return vs Industry: A317690 underperformed the KR Biotechs industry which returned 40% over the past year.
Return vs Market: A317690 underperformed the KR Market which returned 184.4% over the past year.
Price Volatility
| A317690 volatility | |
|---|---|
| A317690 Average Weekly Movement | 9.7% |
| Biotechs Industry Average Movement | 10.8% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in KR Market | 16.3% |
| 10% least volatile stocks in KR Market | 4.8% |
Stable Share Price: A317690 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A317690's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 88 | Sung Hoon Kwon | www.quantamatrix.com |
QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease; and Quanti9 and QuantiGal, a prognostic prediction kit for cardiovascular diseases. QuantaMatrix Inc. was founded in 2010 and is based in Seoul, South Korea.
QuantaMatrix Inc. Fundamentals Summary
| A317690 fundamental statistics | |
|---|---|
| Market cap | ₩77.62b |
| Earnings (TTM) | -₩19.46b |
| Revenue (TTM) | ₩3.69b |
Is A317690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A317690 income statement (TTM) | |
|---|---|
| Revenue | ₩3.69b |
| Cost of Revenue | ₩2.08b |
| Gross Profit | ₩1.61b |
| Other Expenses | ₩21.07b |
| Earnings | -₩19.46b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -966.50 |
| Gross Margin | 43.72% |
| Net Profit Margin | -527.63% |
| Debt/Equity Ratio | 22.0% |
How did A317690 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/12 11:13 |
| End of Day Share Price | 2026/05/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
QuantaMatrix Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.